Sign In
to Vote &
Create Storyboards.
 
Kodak Pivots to Drug Production with $765M US Loan, Stock Skyrockets Kodak’s stock skyrocketed severalfold today, and it had nothing to do with the company’s long-established business in the world of photography. News broke that Kodak had secured at $765 million loan from the US government to shift its attention to producing ingredients for generic drugs. The Wall Street Journal reports that Kodak received the first […]
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard